Pharmanovia are happy to inform that as per 1st of April, 2016, the UK based Atnahs Group has acquired a majority stake in Pharmanovia. [pdf]


NordMedica International A/S changes its name to Pharmanovia A/S as per 1st of June, 2013. Please refer to the following press release: [pdf]



Pharmanovia is a privately held specialty pharmaceutical company focused on the commercialization and marketing of niche pharmaceutical products and medical devices in specific therapeutic areas.

Our business concept is twofold:

  • Acquiring well established, original medicinal products from international pharmaceutical companies to be marketed mainly to hospitals within the EU.
  • We support international pharmaceutical companies in their endeavor to market and distribute pharmaceutical products and medical devises in the Nordic area.

Pharmanovia possess extensive international management experience from the pharmaceutical industry, acquired in the Nordic area, Europe and Japan. This experience secures our customers in hospitals and pharmacies as well as our business partners  in the industry a competent and professional service.

Upcoming Events - Visit our Booth

Scandinavian Association of Digestive Endoscopy (SADE) Conference , 19-20 January 2017, Copenhagen, Denmark

Onkologidagarna, 20-24 March 2017, Örebro, Sweden

Gastrodagarna,17-19 May 2017, Gothenburg, Sweden

The 2nd European Emergency Medical Services Congress (EMS), 22-24 May 2017, Copenhagen, Denmark

Annual meeting at The Danish Society of Gastroenterology and Hepatology (DSGH), 1-2 September 2017, Hindsgavl, Denmark

The European Society for Medical Oncology (ESMO), 8-12 September 2017, Madrid, Spain